Designed by and for the generic industry, we offer Intelligent sourcing and acquisition tools based on a deep understanding of industry requirements
We offer the largest qualified database of available and in-development generic products.
Our database adheres to strict standards of data quality validated and assessed independently to ensure accuracy.
Regulatory documentation and manufacturing approvals support our services.
Commercial awareness and confidential sensitivity of the industry are our key areas of focus.
Our services are the most effective way to promote your products directly to in-licensing and business development teams across the global generics industry.
Significantly increase your partnering opportunities by worldwide exposure to potential clients.
We offer powerful promotional opportunities to launch new products or increase your company profile to the people who matter to your business.
Keep potential clients informed of product development news through our tools.
Industry leading profiles designed by licensing experts will give potential clients the information they need to make decisions about your company and products.
We are the first place to look for generic dossiers and licenses.
Detailed product and company profiles will help you select potential partners and provide the information to assist with decision making.
Our comprehensive notifications system will keep you informed of updates from developers.
Validated data and documentation checks will give you confidence when evaluating potential suppliers

"As partnering and licensing continue to take on ever increasing strategic relevance, a service such as this can be invaluable, saving time and resource when searching for candidates"
Business Development Teva UK
"I like the idea of pre-auditing dossiers and facilities would certainly help reduce the risk of licensing products from new partners; I hope Genericlicensing.com goes from strength to strength."
Winthrop Pharmaceuticals, Business Development
Ind-Swift Ltd. is a leading research driven Healthcare Management Company manufacturing and marketing World Class Pharmaceutical Products. We have dedicated R&D center (s), Manufacturing plant (s) and Marketing team (s). We provide complete product development , manufacturing and packaging services for solid oral dosage forms. We have state of the art manufacturing plant, which is built to meet US- FDA , MHRA – U.K, TGA – Australia, MCC – South Africa and WHO – GMP standards.
Hydrocotisone Sodium Succinate
Injection; 100 mg; No regulatory position
Glucosamine HCl + Chondroitin Sulfate
Sachet; 1500mg + 1200mg ; No regulatory position
Established in 1968 in India, Lupin’s vision is to be an innovation led transnational pharmaceutical company. Lupin is amongst the top 5 Indian pharmaceutical companies with world class EU GMP and USFDA approved manufacturing facilities. Lupin aims to be the partner of choice for economic and high quality pharmaceutical development and manufacture.
Capsule; 30 mg, 60 mg, 90 mg; No regulatory position
Tablet; 20 mg, 40 mg; DCP slot booked
"BCPP is the leader in the Ukraine pharmaceutical market and big Ukrainian manufacture of branded generic drugs and original drugs. BCPP manufacturing capacity enables us to offer a wide range of manufacturing services. "
Tablet; 2 mg, 5 mg; Product License granted ( Ukraine Armenia Belarus Georgia Moldova Tadjikistan Uzbekistan)
Suspension; 100 mg / 5 ml; Product License granted (Ukraine)
You can browse generic products by therapeutic class.
Generics Series: South East Asia Generic Regulations
Genericlicensing.com/Garivaan (55 pages), published Sep 2009
A new report for those companies looking into the future of the generic industry for new growth; an insight into the regulatory environment for the registration of products in South East Asia.
Book your consultation slot now!
Simply contact us to discuss advertising or partnership agreement.